Saby George

phase_1

Dalteparin

phase_1

Pazopanib Hydrochloride

phase_1_2

Therapeutic Hydrocortisone

phase_1_2

tivozanib

not_applicable

Computed Tomography

national-cancer-institute-nci

phase_1_2

+9 more interventions

17 unique interventions2 categories

Analytics

Trial Phases

Phase 14

Phase 24

Trial Status

Completed2

Terminated1

Other3

Role Distribution

Principal Investigator6

PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT01769885Not ApplicableWithdrawn

Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer

Stage II Renal Cell CancerStage III Renal Cell Cancer

PrincipalinvestigatorStart date: 2013-03-14

NCT01684397Phase 1/2Active Not Recruiting

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer

PrincipalinvestigatorStart date: 2012-11-21

NCT01061411Phase 1Completed

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Clear Cell Sarcoma of the KidneyRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer+1 more

PrincipalinvestigatorStart date: 2010-02-06

NCT01038778Phase 1/2Active Not Recruiting

Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more

PrincipalinvestigatorStart date: 2009-10-29

NCT00536991Phase 1/2Terminated

Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer

Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage III Prostate Cancer+1 more

Principalinvestigator

NCT02159950Phase 2Completed

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Clear Cell Renal Cell Carcinoma2 Recurrent Prostate Carcinoma2 Stage III Renal Cell Cancer2 Stage IV Prostate Cancer2 Stage IV Renal Cell Cancer2 Clear Cell Sarcoma of the Kidney1 Hormone-Resistant Prostate Cancer1 Metastatic Kidney Carcinoma1

Affiliations

Roswell Park Cancer Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

22 trials

Shared therapeutic areas:

Prostate AdenocarcinomaMetastatic Prostate CarcinomaClear Cell Renal Cell Carcinoma+4 more

Worked with same sponsors:

Prostate AdenocarcinomaMetastatic Prostate CarcinomaHormone-Resistant Prostate Cancer+1 more

Similarity Score14%

Michael Schweizer

Fred Hutch/University of Washington Cancer Consortium

11 trials

Shared therapeutic areas:

Worked with same sponsors:

Clear Cell Renal Cell CarcinomaStage IV Renal Cell CancerStage III Renal Cell Cancer

Similarity Score8%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

12 trials

Shared therapeutic areas:

Worked with same sponsors:

Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaProstate Adenocarcinoma

Similarity Score6%

Jeremie Calais

UCLA / Jonsson Comprehensive Cancer Center

9 trials

Shared therapeutic areas:

Worked with same sponsors:

Stage IV Prostate CancerStage III Prostate Cancer

Similarity Score6%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

62 trials

Shared therapeutic areas:

Prostate AdenocarcinomaStage III Prostate Cancer

Glenn Lesser, MD

Wake Forest University Health Sciences

10 trials

Shared therapeutic areas:

Worked with same sponsors:

Metastatic Prostate CarcinomaRecurrent Prostate Carcinoma

A P Chen

National Cancer Institute LAO

8 trials

Shared therapeutic areas:

Worked with same sponsors:

Prostate AdenocarcinomaRecurrent Prostate Carcinoma

Amar Kishan

UCLA / Jonsson Comprehensive Cancer Center

7 trials

Shared therapeutic areas: